For a long time, patients suffering from non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma only had one option to turn to for successful treatment. Mohs surgery, developed by general surgeon Frederik E. Mohs in 1938, involves removing one thin layer of tissue from the afflicted area at a time and examination of the tissue to check for the presence of cancer cells. If cancer cells are found, another layer of tissue is removed until the examination turns up a negative result. Once surgeons deem the area in question cancer-free, the surgery is complete. Unfortunately, this surgery can often require deep cuts into the skin, often on the face, that leave painful wounds and scars.
Sensus Healthcare offers a newer, more revolutionary treatment option: the SRT-100™. The treatment involves a precise, calibrated dose of Superficial Radiotherapy that safely and effectively destroys basal and squamous cell carcinomas.
Here is how SRT therapy compares to Mohs surgery with pain, time, and results.
If you’re interested in learning more about a quick, painless, successful alternative to Mohs surgery for your basal or squamous cell carcinoma skin cancer, contact Sensus Healthcare today.